TheRightDoctors Logo
Pre Alpha
Insights from the world's best medical minds
nine
Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Monograph: A physician’s guide to Atrial Fibrillation

Optimum Anticoagulation can minimize the risk of stroke by two-thirds or more

Dr. PC Manoria


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Role Of PET And SPET In Myocardial Viability

Dr. GN Mahapatra


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

In the future, the more the cooperation, the technology and the industry, the more bigger the heights that will be reached.

Dr. HK Chopra, Dr. J Shiv Kumar, Dr. Viveka Kumar


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

New thrombolytic agents better than the older options

Tenecteplase has many advantages over streptokinase, but is also ten times pricier.

Dr. Tiny Nair


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

The challenges of treating Atrial fibrillation

With respect to coronary artery disease worldwide, we have almost reached zenith

Dr. P Manokar


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

A guide to STEMI

Data and statistics about medication will help understand STEMI more clearly

Dr. HK Chopra


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Untreated Atrial Fibrillation would lead to 4% incidence of strokes

Prevention of stroke and rhythm correction are the two goals of treatment for Atrial Fibrillation

Dr.Nishith Chandra


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Heart Failure and Atrial Fibrillation: Epidemic of the next decade

Primary prevention in India is a utopian dream

Dr. P Manokar


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Drugs in Atrial Fibrillation: Old and new

Vitamin K Antagonists have been the gold standard because of their efficacy, availability and cost effectiveness but the New Anticoagulants have a bright future

Dr. PB Jayagopal


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Undetected non-valvular Atrial Fibrillation (AF) prevalent in Indians

AF is 35% related to Rheumatic Valvular Disease, 30% to degenerative valvular disease in elderly patients, 20 % to cardiomyopathy, and 20% comprises non-valvular AF

Dr. Guruprasad Sogunuru


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Management of STEMI in the absence of PCI

Less than 5 to 10% of the PCI facilities cater to tier 2 and tier 3 cities

Dr. Sreenivas Kumar


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Arrhythmias: Diagnosis and treatment

The classic antiarrhythmic drugs like amiodarone and sotalol are double edged swords

Dr. Ajay Naik


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Newer anti-platelets over clopidogrel

Ticagrelor and prasugrel overcome drawbacks at the risk of increased bleeding

Dr. JS Hiremath


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Invasive treatment only for high-risk heart patients ?

All emergency cases involving chest pain must get angiography, irrespective of risk profile

Dr. Anil Kumar


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Stroke during PCI: Precaution is prevention

Depending on the age and comorbidity, the incidence of a stroke during an intervention is 0.6%

Dr. Viveka Kumar


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Heart Attack: A casualty in youngsters

At least 25% to 30% of heart attacks occur in people less than 40 years of age, sometimes even at 25.

Dr. PK Goel


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Triglyceride: An important risk factor for Coronary Artery Disease

High triglyceride and low HDL cholesterol found more in Indians than in the West

Dr. Dhiman Kahali


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Higher risk of repeat attack with non-reperfused STEMI

A study in Vellore shows that the problem of non-reperfused STEMI goes up to 30%

Dr. PB Jayagopal


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Déjà vu very rare for post bypass cases

There are no guidelines for post CABG patients as their occurrence is less than 10%

Dr. I Satyamurthy


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

ACE Inhibitors or ARBs?

ARBs are a good option for patients who are ACE intolerant.

Dr. Harsh Wardhan


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Drug talk: Anticoagulation and STEMI

After 55 long years comes a new generation of anticoagulation drugs with many advantages over the old ones.

Dr. JS Hiremath


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

PCSK9 and ezetimibe: non-statin agents for dyslipidemia

Dyslipidemia accounts for 50% of coronary heart disease

Dr. PC Manoria


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Effective management of STEMI in India

In India, there are about 3.5 to 4 million individuals who develop STEMI and 95% do not reach hospital in time for treatment.

Dr. DB Pahlajani


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Life after a heart attack

Chances of having a repeat attack are only 5% in five years

Dr. S Ramakrishnan


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Management of STEMI with renal failure

Angioplasty not a possibility for a STEMI patient with a renal failure: a myth

Dr. Sandeep Bansal


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Access to angioplasty: 20% in US and 3% in Delhi

Delay in treatment is a major cause of loss of lives due to heart attack

Dr. HK Chopra, Dr. Viveka Kumar, Dr. Satyavan Sharma


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Pharmaco-invasive strategy in STEMI-Dr.Swan Ganz memorial oration

Dr. Ajith Mullasari


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Metabolic Syndrome in Indians

Pointers: High non-HDL cholesterol, triglycerides and insulin resistance

Dr. AK Pancholia


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Metabolic Syndrome in India: is it different?

Dr. AK Pancholia


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Role of beta blockers indispensable in acute MI

Beta blockers when administered early after the onset of acute MI showed 25% to 36% reduction in early and late mortality.

Dr. KK Sethi


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

We need Systems of Care to Treat Heart Attacks

The system initiates a whole series of events that ensures treatment of the patient within 24 hours.

Dr. Ajith Mullasari


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Attack heart attack with the Smart Heart App

The potential of tenecteplase cannot be over-emphasized in treatment of heart attack

Dr. HK Chopra


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Interventions in Anamalous Coronary Arteries

Tips in doing Interventions in Anamalous Coronary Arteries

Dr. DB Pahlajani


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

The Presidential Address at CSI-NIC 2016

Dr. Guha Talks About The Success Of The NIC, And The Path Forward

Dr. Santanu Guha


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Coronary Physiology and Imaging

Strain Imaging in Planning for Multi Vessel PCI

Dr. Rakesh Gupta


Dr. SK Parashar, Senior Cardiologist, Metro Hospital, Delhi

Dr.Vivek Gupta